X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (37) 37
index medicus (36) 36
oncology (31) 31
melanoma (30) 30
immunotherapy (23) 23
cancer (20) 20
ipilimumab (20) 20
female (18) 18
metastasis (17) 17
male (16) 16
middle aged (15) 15
aged (14) 14
care and treatment (14) 14
melanoma - drug therapy (14) 14
tumors (14) 14
article (13) 13
adult (12) 12
immunology (12) 12
antibodies, monoclonal - therapeutic use (11) 11
metastatic melanoma (11) 11
research (11) 11
therapy (11) 11
hematology, oncology and palliative medicine (10) 10
nivolumab (10) 10
clinical trials (9) 9
drug therapy (9) 9
health aspects (9) 9
melanoma - pathology (9) 9
pd-1 (9) 9
cell lung-cancer (8) 8
cytotoxicity (8) 8
mutation (8) 8
skin neoplasms - pathology (8) 8
abridged index medicus (7) 7
aged, 80 and over (7) 7
antibodies, monoclonal - adverse effects (7) 7
antineoplastic agents - therapeutic use (7) 7
antineoplastic combined chemotherapy protocols - therapeutic use (7) 7
apoptosis (7) 7
ctla-4 blockade (7) 7
melanoma - immunology (7) 7
melanoma - therapy (7) 7
patients (7) 7
pd-1 blockade (7) 7
pembrolizumab (7) 7
safety (7) 7
usage (7) 7
antibodies, monoclonal - administration & dosage (6) 6
blockade (6) 6
chemotherapy (6) 6
expression (6) 6
immune checkpoint (6) 6
melanoma - genetics (6) 6
pd-1 protein (6) 6
research article (6) 6
skin neoplasms - drug therapy (6) 6
treatment outcome (6) 6
tumor microenvironment (6) 6
analysis (5) 5
animals (5) 5
antibody (5) 5
antigens (5) 5
drug dosages (5) 5
guidelines (5) 5
immune response (5) 5
inhibitors (5) 5
lymphocytes (5) 5
lymphocytes t (5) 5
patient outcomes (5) 5
programmed cell death 1 receptor - antagonists & inhibitors (5) 5
solid tumors (5) 5
studies (5) 5
t cells (5) 5
anti-pd-1 (4) 4
antineoplastic agents - adverse effects (4) 4
b7-h1 (4) 4
biomarkers (4) 4
brain neoplasms - secondary (4) 4
cancer therapies (4) 4
clinical trials as topic (4) 4
complications and side effects (4) 4
ctla-4 antigen - antagonists & inhibitors (4) 4
cytokines (4) 4
dendritic cells (4) 4
disease progression (4) 4
disease-free survival (4) 4
drugs (4) 4
improved survival (4) 4
inhibition (4) 4
kaplan-meier estimate (4) 4
kinases (4) 4
medicine, general & internal (4) 4
medicine, research & experimental (4) 4
mek inhibition (4) 4
melanoma - mortality (4) 4
melanoma - secondary (4) 4
neoplasm metastasis (4) 4
neoplasms. tumors. oncology. including cancer and carcinogens (4) 4
open-label (4) 4
pd-l1 protein (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 4, pp. 375 - 384
Journal Article
Lancet, The, ISSN 0140-6736, 2014, Volume 384, Issue 9948, pp. 1109 - 1117
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 8, pp. 908 - 918
Journal Article
Journal Article
Journal Article
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2017
Abstract Purpose Immune checkpoint inhibitors are increasingly used in the treatment of metastatic cancers and associated with immune-related adverse events... 
Radiology | Hematology, Oncology and Palliative Medicine
Journal Article
by Althammer, Sonja and Steele, Keith and Rebelatto, Marlon and Tan, Tze Heng and Wiestler, Tobias and Schmidt, Guenter and Higgs, Brandon and Li, Xia and Shi, Li and Jin, Xiaoping and Antal, Joyce and Gupta, Ashok and Ranade, Koustubh and Binning, Gerd and Bellmunt, Joaquim and de Wit, Ronald and Vaughn, David J and Fradet, Yves and Lee, Jae Lyun and Fong, Lawrence and Vogelzang, Nicholas J and Climent, Miguel A and Petrylak, Daniel P and Choueiri, Toni K and Necchi, Andrea and Gerritsen, Winald and Gurney, Howard and Quinn, David I and Culine, Stéphane and Sternberg, Cora N and Mai, Yabing and Puhlmann, Markus and Perini, Rodolfo F and Bajorin, Dean F and Sharma, Padmanee and Callahan, Margaret K and Calvo, Emiliano and Kim, Joseph W and de Braud, Filipo and Ott, Patrick A and Bono, Petri and Pillai, Rathi N and Morse, Michael and Le, Dung T and Taylor, Matthew and Spilliopoulou, Pavlina and Bendell, Johanna and Jaeger, Dirk and Chan, Emily and Antonia, Scott J and Ascierto, Paolo A and Hennicken, Delphine and Tschaika, Marina and Azrilevich, Alex and Rosenberg, Jonathan and Levy, Ofer and Chan, Christopher and Cojocaru, Gady and Liang, Spencer and Ophir, Eran and Ganguly, Sudipto and Toporik, Amir and Kotturi, Maya and Kfir, Tal Fridman and Murter, Benjamin M and Logronio, Kathryn and Dassa, Liat and Leung, Ling and Greenwald, Shirley and Azulay, Meir and Kumar, Sandeep and Alteber, Zoya and Pan, Xiaoyu and Machlenkin, Arthur and Benita, Yair and Drake, Andrew W and Chajut, Ayelet and Salomon, Ran and Vankin, Ilan and Safyon, Einav and Hunter, John and Levine, Zurit and White, Mark and Leidner, Rom and Kang, Hyunseok and Haddad, Robert and Segal, Neil H and Wirth, Lori J and Ferris, Robert L and Hodi, F. Stephen and Sanborn, Rachel E and Gajewski, Thomas F and Sharfman, William and McDonald, Dan and Srivastava, Shivani and Gu, Xuemin and Phillips, Penny and Passey, Chaitali and Seiwert, Tanguy and Habtetsion, Tsadik and ...
Journal for ImmunoTherapy of Cancer, ISSN 2051-1426, 12/2016, Volume 4, Issue S2
Journal Article
Journal Article